Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06161285
What this trial is testing

Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants

Who this might be right for
Bronchiolitis
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Study completedNCT00192478
What this trial is testing

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 217
Not applicableStudy completedNCT01734668
What this trial is testing

Sofia RSV FIA Field Study

Who this might be right for
Respiratory Syncytial Virus
Quidel Corporation 2,468
Testing effectiveness (Phase 2)Study completedNCT05559905
What this trial is testing

Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)

Who this might be right for
Respiratory Syncytial Virus
Merck Sharp & Dohme LLC 116
Testing effectiveness (Phase 2)Ended earlyNCT06784973
What this trial is testing

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
RSV Infection
Gilead Sciences 4
Not applicableStudy completedNCT02067286
What this trial is testing

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Who this might be right for
Influenza AInfluenza BRespiratory Syncytial Virus (RSV)
IQuum, Inc. 1,642
Large-scale testing (Phase 3)Active Not RecruitingNCT07203365
What this trial is testing

RSV Immunogenicity Study in the Elderly (RISE)

Who this might be right for
RSV Immunisation
Karin Karin Loré 75
Not applicableStudy completedNCT00263900
What this trial is testing

TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit

Who this might be right for
InfluenzaRespiratory Syncytial Viruses
University Hospital, Rouen 377
Large-scale testing (Phase 3)Study completedNCT06060457
What this trial is testing

Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,900
Large-scale testing (Phase 3)Active Not RecruitingNCT05035212
What this trial is testing

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

Who this might be right for
Lower Respiratory Tract Illness
Pfizer 38,861
Large-scale testing (Phase 3)Looking for participantsNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Testing effectiveness (Phase 2)Study completedNCT03606512
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus
Janssen Vaccines & Prevention B.V. 38
Testing effectiveness (Phase 2)Study completedNCT05687279
What this trial is testing

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Who this might be right for
Respiratory Syncytial Virus Infection
Sanofi Pasteur, a Sanofi Company 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07208461
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Guangzhou Patronus Biotech Co., Ltd. 700
Early research (Phase 1)Study completedNCT02952339
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Not applicableStudy completedNCT06746051
What this trial is testing

Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants

Who this might be right for
RSV Infections
Shionogi 100
Early research (Phase 1)Study completedNCT02231671
What this trial is testing

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 12
Early research (Phase 1)Study completedNCT02290340
What this trial is testing

A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants

Who this might be right for
Respiratory Syncytial Virus
MedImmune LLC 151
Not applicableStudy completedNCT05765396
What this trial is testing

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)

Who this might be right for
COVID-19SARS-CoV-2 VirusCOVID-19 Pneumonia+5 more
The Geneva Foundation 300
Not applicableStudy completedNCT00246480
What this trial is testing

RSV Disease in the Elderly

Who this might be right for
Respiratory Infections, AcuteRespiratory Syncytial Virus
National Institute of Allergy and Infectious Diseases (NIAID) 1,401
Next Page